Efficacy of anakinra on rebound of multisystem inflammatory syndrome

Pediatr Int. 2022 Jan;64(1):e15337. doi: 10.1111/ped.15337.
No abstract available

Keywords: MIS-C; SARS-CoV-2; acute pericarditis; anakinra; multisystem inflammatory syndrome in children.

MeSH terms

  • COVID-19*
  • Humans
  • Interleukin 1 Receptor Antagonist Protein* / therapeutic use
  • SARS-CoV-2
  • Systemic Inflammatory Response Syndrome / diagnosis
  • Systemic Inflammatory Response Syndrome / drug therapy

Substances

  • Interleukin 1 Receptor Antagonist Protein